Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation

Research output: Contribution to journalArticlepeer-review

Abstract

In this report it is shown that intravenous formulation of isavuconazole could be administered 5/7 days a week in patients who can not swallow capsules, once the steady state has been stably reached and maintained, thanks to its very long half-life. In this case TDM should be highly recommended.

Original languageEnglish
Pages (from-to)217-218
Number of pages2
JournalJournal of Chemotherapy
Volume32
Issue number4
DOIs
Publication statusPublished - Jul 2020

Fingerprint Dive into the research topics of 'Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation'. Together they form a unique fingerprint.

Cite this